Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:00:25.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden message with a Home link instead of its usual study content.
    Difference
    0.5%
    Check dated 2026-10-05T17:18:17.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page with the standard header/footer and revision notice, replacing the expected study details.
    Difference
    16%
    Check dated 2026-09-21T22:24:19.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page reflects a new revision tag (v3.6.6), indicating a routine behind-the-scenes deployment update.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:36.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The revision label at the bottom updates from v3.6.4 to v3.6.5, indicating a new page release. This change updates the page metadata without altering the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-10T14:28:32.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.3 to v3.6.4, reflecting a minor site update. No study content or functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-07-27T06:32:35.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.